Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
An update from Regeneus Ltd. ( (AU:CMB) ) is now available.
Cambium Bio Limited, a company involved in the biotechnology sector, announced the settlement of a share placement initiated in December 2024, raising AUD$ 2,950,001.44 through the issuance of 6,361,875 ordinary shares. The company has now issued 862,627 fully paid ordinary shares at an issue price of AUD$ 0.4637 per share. This placement was made to sophisticated institutional and private investors without the need for disclosure under Part 6D.2 of the Corporations Act 2001, confirming the company’s compliance with the relevant statutory provisions.
More about Regeneus Ltd.
YTD Price Performance: -7.50%
Average Trading Volume: 10,771
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$4.91M
For an in-depth examination of CMB stock, go to TipRanks’ Stock Analysis page.
